Clinical Trial Update: Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating adipose-derived stem cells for moderate to severe chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• To Severe Chronic Kidney Disease

Drugs mentioned

• Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: UnicoCell Biomed CO. LTD | Conditions: Moderate to Severe Chronic Kidney Disease | Phase 1, Phase 2 | Status: COMPLETED